CDC, hepatitis B and vaccine

Digest more
CDC vaccine advisory committee meets to discuss hepatitis B shot, childhood schedule
It marks the third meeting this year of the Advisory Committee on Immunization Practices (ACIP) since Health and Human Services Secretary Robert F. Kennedy Jr. fired all 17 members, replacing them with his own hand-selected picks, many of whom have expressed vaccine-skeptic views.

Continue reading

CDC panel postpones vote on hepatitis B vaccine for newborns, discusses childhood immunization schedule
CDC advisory panel delays vote on hepatitis B vaccines after unruly, misinformation-filled meeting
Kennedy’s handpicked CDC advisers to weigh major change to childhood vaccine schedule
Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the childhood vaccine schedule, potentially delaying a dose of the hepatitis B vaccin...

Continue reading

CDC poised to decide on hep B vaccine for newborns amid pressure from Trump officials
RFK Jr.'s vaccine advisory committee delays vote on hepatitis B shots for newborns
Kennedy advisers delay vote to drop hepatitis B vaccine recommendation, a major policy shift
If the recommendation for the hepatitis B vaccine is delayed past ages 2 or 3 months, pediatricians might avoid using those combination vaccines, Demetre Daskalakis, former director at the CDC's Natio...

Continue reading

CDC vaccine panel delays hepatitis B vote amid chaotic meeting
US vaccine committee's hepatitis B changes would be most consequential yet

Hepatitis B: What parents should know about the virus and the vaccine

For decades, newborns in the U.S. have been given the hepatitis B vaccine. This could change. A CDC vaccine advisory panel may vote to end that routine vaccination. Here's what parents should know.

What to know about the hepatitis B shot — and why Trump officials are targeting it

Dr. Baruch Blumberg, a federal scientist, identified the virus behind the infection in 1965. He won the Nobel Prize for the discovery, which led to tests and vaccines. The first hepatitis B vaccine was licensed in the U.S. in 1981.

The Journey To Hepatitis B Elimination Through Innovation, Early Testing, And Scientific Discovery

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that policymakers set clear elimination targets for hepatitis B, coordinate efforts, enhance surveillance, and create supportive regulatory environments to support this.
STAT

Expert review finds delaying the hepatitis B vaccine birth dose would increase chronic infections in kids

Delaying the timing of vaccinating infants against hepatitis B — which ACIP could vote on later this week — would likely lead to more chronic infections in kids.
Feedback